Cargando…

Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura

A 53-year-old man was admitted to a peripheral hospital with the diagnosis of acute myocardial infarction without ST elevation. Due to the concomitant presence of first-diagnosed thrombocytopenia (platelet count 50.000/μL), it was decided to be treated conservatively with clopidogrel. Five days late...

Descripción completa

Detalles Bibliográficos
Autores principales: Iakovis, Nikolaos, Xanthopoulos, Andrew, Chamaidi, Aikaterini, Papamichalis, Michail, Dimos, Apostolos, Triposkiadis, Filippos, Skoularigis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093901/
https://www.ncbi.nlm.nih.gov/pubmed/32231806
http://dx.doi.org/10.1155/2020/6738348
_version_ 1783510368115490816
author Iakovis, Nikolaos
Xanthopoulos, Andrew
Chamaidi, Aikaterini
Papamichalis, Michail
Dimos, Apostolos
Triposkiadis, Filippos
Skoularigis, John
author_facet Iakovis, Nikolaos
Xanthopoulos, Andrew
Chamaidi, Aikaterini
Papamichalis, Michail
Dimos, Apostolos
Triposkiadis, Filippos
Skoularigis, John
author_sort Iakovis, Nikolaos
collection PubMed
description A 53-year-old man was admitted to a peripheral hospital with the diagnosis of acute myocardial infarction without ST elevation. Due to the concomitant presence of first-diagnosed thrombocytopenia (platelet count 50.000/μL), it was decided to be treated conservatively with clopidogrel. Five days later, he developed an acute myocardial infarction with ST elevation (STEMI) and was transferred to our department for primary percutaneous coronary intervention (PCI). Coronary angiography revealed three-vessel disease. The left anterior descending lesion was considered culprit, and PCI was successfully performed using a drug-eluting balloon. This approach was considered safer due to the risk of intolerance of prolonged dual antiplatelet therapy in case of stent implantation. Indeed, four days later, aspirin was discontinued, and the patient remained only on clopidogrel due to a platelet fall. Meanwhile, idiopathic thrombocytopenic purpura (ITP) was diagnosed by hematology consultation, and specific ITP treatment was initiated. Seven days following the procedure, the patient was transferred to the Hematology clinic, where a continuous rise of platelet count up to 115.000/μL while on clopidogrel was observed, and he was discharged from the hospital asymptomatic. Unfortunately, twenty days later, the patient died of a lung infection. In ITP patients with STEMI, primary PCI with drug-eluting balloon angioplasty may be a reasonable approach.
format Online
Article
Text
id pubmed-7093901
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70939012020-03-30 Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura Iakovis, Nikolaos Xanthopoulos, Andrew Chamaidi, Aikaterini Papamichalis, Michail Dimos, Apostolos Triposkiadis, Filippos Skoularigis, John Case Rep Cardiol Case Report A 53-year-old man was admitted to a peripheral hospital with the diagnosis of acute myocardial infarction without ST elevation. Due to the concomitant presence of first-diagnosed thrombocytopenia (platelet count 50.000/μL), it was decided to be treated conservatively with clopidogrel. Five days later, he developed an acute myocardial infarction with ST elevation (STEMI) and was transferred to our department for primary percutaneous coronary intervention (PCI). Coronary angiography revealed three-vessel disease. The left anterior descending lesion was considered culprit, and PCI was successfully performed using a drug-eluting balloon. This approach was considered safer due to the risk of intolerance of prolonged dual antiplatelet therapy in case of stent implantation. Indeed, four days later, aspirin was discontinued, and the patient remained only on clopidogrel due to a platelet fall. Meanwhile, idiopathic thrombocytopenic purpura (ITP) was diagnosed by hematology consultation, and specific ITP treatment was initiated. Seven days following the procedure, the patient was transferred to the Hematology clinic, where a continuous rise of platelet count up to 115.000/μL while on clopidogrel was observed, and he was discharged from the hospital asymptomatic. Unfortunately, twenty days later, the patient died of a lung infection. In ITP patients with STEMI, primary PCI with drug-eluting balloon angioplasty may be a reasonable approach. Hindawi 2020-03-13 /pmc/articles/PMC7093901/ /pubmed/32231806 http://dx.doi.org/10.1155/2020/6738348 Text en Copyright © 2020 Nikolaos Iakovis et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Iakovis, Nikolaos
Xanthopoulos, Andrew
Chamaidi, Aikaterini
Papamichalis, Michail
Dimos, Apostolos
Triposkiadis, Filippos
Skoularigis, John
Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura
title Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura
title_full Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura
title_fullStr Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura
title_full_unstemmed Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura
title_short Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura
title_sort recurrent acute coronary syndromes in a patient with idiopathic thrombocytopenic purpura
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093901/
https://www.ncbi.nlm.nih.gov/pubmed/32231806
http://dx.doi.org/10.1155/2020/6738348
work_keys_str_mv AT iakovisnikolaos recurrentacutecoronarysyndromesinapatientwithidiopathicthrombocytopenicpurpura
AT xanthopoulosandrew recurrentacutecoronarysyndromesinapatientwithidiopathicthrombocytopenicpurpura
AT chamaidiaikaterini recurrentacutecoronarysyndromesinapatientwithidiopathicthrombocytopenicpurpura
AT papamichalismichail recurrentacutecoronarysyndromesinapatientwithidiopathicthrombocytopenicpurpura
AT dimosapostolos recurrentacutecoronarysyndromesinapatientwithidiopathicthrombocytopenicpurpura
AT triposkiadisfilippos recurrentacutecoronarysyndromesinapatientwithidiopathicthrombocytopenicpurpura
AT skoularigisjohn recurrentacutecoronarysyndromesinapatientwithidiopathicthrombocytopenicpurpura